申请人:Ancliff Ann Rachael
公开号:US20060063765A1
公开(公告)日:2006-03-23
Compounds of formula (I):
wherein:
R
1
represents substituted or unsubstituted heteroaryl;
Y represents —(CR
na
R
nb
)
n
—;
R
na
and R
nb
are each independently hydrogen or C
1-6
alkyl; n is an integer from 0 to 5;
R
2
represents unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl;
R
3
and R
4
each independently represent hydrogen or C
1-6
alkyl;
R
7
represents hydrogen or C
1-6
alkyl;
R
8
represents hydrogen or C
1-6
alkyl; and salts and solvates thereof; are CCR3 antagonists and are thus indicated to be useful in therapy.
式(I)的化合物:
其中:
R1代表取代或未取代的杂环芳基;
Y代表—(CRnaRnb)n—;
Rna和Rnb各自独立地代表氢或C1-6烷基;
n为0到5的整数;
R2代表未取代或取代的芳基或未取代或取代的杂环芳基;
R3和R4各自独立地代表氢或C1-6烷基;
R7代表氢或C1-6烷基;
R8代表氢或C1-6烷基;
它们的盐和溶剂化物是CCR3拮抗剂,因此被认为在治疗中有用。